Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Selecta Biosciences Inc.

    NASDAQ: SELB · Real-Time Price · USD
    0.88
    -0.08 (-8.12%)
    At close: Nov 13, 2023, 10:00 PM

    Selecta Biosciences Statistics

    Share Statistics

    Selecta Biosciences has 153.43M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 153.43M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 94M

    Failed to Deliver (FTD) Shares

    n/a
    		 8

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 7.98M, so 5.2% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 7.98M

    Short % of Shares Out

    n/a
    		 5.2%

    Short % of Float

    n/a
    		 7.8%

    Short Ratio (days to cover)

    n/a
    		 17.33

    Valuation Ratios

    The PE ratio is -471.1 and the forward PE ratio is null. Selecta Biosciences's PEG ratio is 4.68.

    PE Ratio

    n/a
    		 -471.1

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -235.14

    P/FCF Ratio

    n/a
    		 -2015

    PEG Ratio

    n/a
    		 4.68
    Financial Ratio History

    Enterprise Valuation

    Selecta Biosciences has an Enterprise Value (EV) of 103.44B.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -1196.98

    EV / EBIT

    n/a
    		 -2021.83

    EV / FCF

    n/a
    		 -2013.72

    Financial Position

    The company has a current ratio of 1.33, with a Debt / Equity ratio of -0.02.

    Current Ratio

    n/a
    		 1.33

    Quick Ratio

    n/a
    		 1.33

    Debt / Equity

    n/a
    		 -0.02

    Debt / EBITDA

    n/a
    		 -0.13

    Debt / FCF

    n/a
    		 -0.21

    Interest Coverage

    n/a
    		 30.5

    Financial Efficiency

    Return on Equity is 49.91% and Return on Invested Capital is 21.74%.

    Return on Equity

    n/a
    		 49.91%

    Return on Assets

    n/a
    		 -72.02%

    Return on Invested Capital

    n/a
    		 21.74%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-3,432,968.75

    Employee Count

    n/a
    		 64

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 19M

    Effective Tax Rate

    n/a
    		 -7.96%

    Stock Price Statistics

    The stock price has increased by 31.87% in the last 52 weeks. The beta is 0.83, so Selecta Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.83

    52-Week Price Change

    n/a
    		 31.87%

    50-Day Moving Average

    n/a
    		 1.07

    200-Day Moving Average

    n/a
    		 1.17

    Relative Strength Index (RSI)

    n/a
    		 37.34

    Average Volume (20 Days)

    n/a
    		 634,418

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -86.42M

    Net Income

    n/a
    		 -219.71M

    EBITDA

    n/a
    		 -86.42M

    EBIT

    n/a
    		 -241.54M

    Earnings Per Share (EPS)

    n/a
    		 0
    Full Income Statement

    Balance Sheet

    The company has 76.91M in cash and 10.96M in debt, giving a net cash position of 65.96M.

    Cash & Cash Equivalents

    n/a
    		 76.91M

    Total Debt

    n/a
    		 10.96M

    Net Cash

    n/a
    		 65.96M

    Retained Earnings

    n/a
    		 -614.65M

    Total Assets

    n/a
    		 305.05M

    Working Capital

    n/a
    		 22.52M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -51.16M and capital expenditures -206K, giving a free cash flow of -51.37M.

    Operating Cash Flow

    n/a
    		 -51.16M

    Capital Expenditures

    n/a
    		 -206K

    Free Cash Flow

    n/a
    		 -51.37M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    SELB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -0.21%

    FCF Yield

    n/a
    		 -0.05%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for SELB.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -3.07

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist